Independence Capital Asset Partners’s Gilead Sciences GILD Stock Holding History

Independence Capital Asset Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-76,374	Closed	-$7.2M	–	92
2014 Q4	$7.2M	Sell	76,374 -42,232	-36%	-$4.37M	0.99%	46
2014 Q3	$12.6M	Buy	+118,606	New	+$11.6M	1.76%	28
2014 Q1	–	Sell	-302,905	Closed	-$22.7M	–	106
2013 Q4	$22.7M	Buy	302,905 +30,485	+11%	+$2.12M	3.46%	6
2013 Q3	$17.1M	Buy	272,420 +5,538	+2%	+$331K	2.91%	10
2013 Q2	$13.7M	Buy	+266,882	New	+$13.9M	2.38%	9

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Independence Capital Asset Partners's GILD Position: Q1 2015 in Review

Independence Capital Asset Partners sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 76,374 shares — an estimated $7.2M sold.

Independence Capital Asset Partners first reported a position in GILD in Q2 2013 and held it in 5 quarters. The position peaked at $22.7M in Q4 2013. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

Independence Capital Asset Partners reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
Independence Capital Asset Partners sold 76,374 Gilead Sciences shares in Q1 2015, an estimated $7.2M.
Independence Capital Asset Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 5 quarters.
Independence Capital Asset Partners's Gilead Sciences position peaked at $22.7M in Q4 2013.
1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Independence Capital Asset Partners's 13F filing for Q1 2015, filed 14 May 2015.